Skip to main content

Table 4 PRB mRNA expression before and after treatment as a function of PRB status on day 1

From: Progesterone receptor isoform A may regulate the effects of neoadjuvant aglepristone in canine mammary carcinoma

  

Median ± SD of PRB expression (2^-∆Ct)

PRB status at day 1

Day 1

Day 15

Control group

PRB+

0.014 ± 0.01

0.010 ± 0.02

PRB-

0.007 ± 0.00

0.007 ± 0.001

Treated group

PRB+

0.014 ± 0.01

0.011 ± 0.01

PRB-

0.006 ± 0.002

0.006 ± 0.003

  1. PRB: Progesterone receptor isoform B; SD: Standard deviation; PRB+: Progesterone receptor isoform B positive; PRB-: Progesterone receptor isoform B negative.